Back
EHRA Premium Access

Pros and cons of human iPSC cardiomyocytes in drug testing and disease modelling: insights from computational modelling

Session: Poster Session 1 - 43rd EWGCCE Meeting
Topic: Cardiac Diseases
Speaker: Doctor J. Koivumaeki (Tampere, FI)
Event: EHRA 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jussi Tapani Koivumaeki

Tampere University, Tampere (Finland)
0 follower

17 more presentations in this session

The hidden electrophysiological cardiotoxic effects of rofecoxib are prevented by ischaemic preconditioning

Speaker: Doctor Z. Husti (Szeged, HU)

Access
Abstract
Like
Thumbnail

A high-throughput system to reliably characterize normal human ventricular electrophysiology from living patients

Speaker: Doctor A. Olivan-Viguera (Zaragoza, ES)

Access
Abstract
Like
Thumbnail

Advanced morpho-functional analysis on ventricular and atrial tissue reveals sarcomere energetic impairment in hcm patients

Speaker: Miss E. Lazzeri (Florence, IT)

Access
Abstract
Like
Thumbnail

Istaroxime improves diabetic diastolic dysfunction through SERCA stimulation

Access
Like
Thumbnail

Mechanism of sinus node dysfunction in carriers of the E161K mutation in the SCN5A gene

Speaker: Assistant Professor R. Wilders (Amsterdam, NL)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1 - 43rd EWGCCE Meeting

Speakers: Doctor J. Koivumaeki, Doctor Z. Husti, Doctor A. Olivan-Viguera, Miss E. Lazzeri, Assistant Professor R. Wilders
Access
Like
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources